HFA
IBB icon

Hoover Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Hoover Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$80K Hold
489
– – 0.01% 222
2021
Q1 		$72K Hold
489
– – 0.01% 229
2020
Q4 		$79K Buy
489
+1
+0.2% +$143 0.02% 198
2020
Q3 		$66K Buy
488
+153
+46% +$20.8K 0.02% 130
2020
Q2 		$46K Buy
+335
New +$42.7K 0.02% 196

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hoover Financial Advisors's IBB Position: Q2 2021 in Review

Hoover Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2021 at 489 shares worth $80K. The position accounts for 0.01% of the portfolio, ranked #222.

Hoover Financial Advisors first reported a position in IBB in Q2 2020 and has held it in 5 quarters since. 863 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • Hoover Financial Advisors held 489 shares of iShares Biotechnology ETF worth $80K as of Q2 2021.
  • Hoover Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2021.
  • iShares Biotechnology ETF made up 0.01% of Hoover Financial Advisors's portfolio in Q2 2021, its #222 holding.
  • Hoover Financial Advisors first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 5 quarters since.
  • 863 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Hoover Financial Advisors's 13F filing for Q2 2021, filed 28 Jul 2021.